厄达替尼纳入医保了吗？

In the past, bladder cancer could only be treated with surgery, radiotherapy and chemotherapy. There was no effective targeted drug specifically used to treat bladder cancer. However, with the advancement of medical technology, there is hope for bladder cancer patients. It is approved by the FDA for the treatment of metastatic bladder cancer. This is a targeted drug that can target EGFR3 or EGFR2 mutations, helping bladder cancer patients who have failed chemotherapy to seize the last hope.

Erdafitinib usage and dosage:

1. The initial dose is 8 mg orally, once a day; increase to 9 mg, orally, once a day based on serum phosphate (PO4) levels and tolerance for 14-21 days.

2. If serum phosphate level is <5.5 mg/dL and there is no eye disease or grade ≥2 adverse reactions, increase the dose to 9 mg once daily.

3. Treat with erdafitinib until disease progression or unacceptable toxicity.

In addition, in July 2019, a British clinical study released the latest clinical treatment data. In this clinical test, 99 patients with advanced bladder cancer and EGFR mutation received erdafitinib treatment. After treatment, the patients' objective response rate reached more than 40%, which helped many bladder cancer patients who failed standard treatments to prolong their lives.

It can be seen that the therapeutic effect of erdafitinib has been effectively verified. Is erdafitinib included in medical insurance?

It is understood that it has not been officially launched in mainland China, so there is no medical insurance to speak of!

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: